functions and show heightened susceptibility to atheroma development and conditions that would favor thrombus accumulation. 3 I fully endorse their assertion of the importance of primary prevention strategies for coronary artery disease.
Kounis cites the pioneering morphologic studies by Constantinides and Harkey that showed open junctions between endothelial cells over human plaques. Since these classic studies, substantial data have highlighted qualitative abnormalities in endothelial function rather than desquamative injury, or physical discontinuities between junctions, as a mechanism of inflammatory-cell recruitment. 3 The expression of selective adhesion molecules on the surface of endothelial cells that have undergone activation by risk factor-related stimuli, and local elaboration of chemoattractant molecules, lead to leukocyte accumulation in lesions, according to current evidence. I agree completely regarding the potential contributions of mast cells and their proteases to atherogenesis -indeed, genetic studies in mice rigorously implicate mast cells in experimental atherogenesis. 4 I further concur with the points raised regarding the roles of mast-cell-derived proteases in the activation of MMPs. In addition to the mast-cell-derived enzymes chymase and tryptase, other serine proteases, including some involved in blood coagulation, such as plasmin and thrombin, can also activate the zymogen forms of MMPs. 5 Peter Libby, M.D. Brigham and Women's Hospital Boston, MA plibby@rics.bwh.harvard.edu Since publication of his article, the author reports no further potential conflict of interest. The presence of asymptomatic or subclinical MERS-CoV infections in the community or among health care workers could have important public health implications, since these infections may be sources of transmission to close contacts in the community or to patients with coexisting medical conditions. The close proximity of health care workers to patients and the handling of human biologic material (sputum, respiratory secretions, feces, urine, or blood) may increase the risk of transmission, and health care workers may be particularly at risk for MERS-CoV infections.
The Saudi Arabian Ministry of Health routinely screens all close contacts of patients in whom MERS-CoV infection has been diagnosed, and more than 3000 people have been screened to date. We recently identified seven health care workers with MERS-CoV infection (two of whom were asymptomatic and five of whom had mild upper respiratory tract symptoms) through screening of single sample nasopharyngeal swabs by means of a real-time reverse-transcriptasepolymerase-chain-reaction (RT-PCR) amplification test, with amplification targeting both the upstream E protein gene (upE) and open reading frame 1a (ORF1a) for confirmation. A patient was confirmed as having MERS-CoV infection if both assays were positive. Table 1 outlines the clinical characteristics of these seven health care workers, and Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org, summarizes their level of contact with patients and the infection-control procedures undertaken. Some of the nurses did not follow infection-control procedures fully and therefore had maximal exposure. All the infected nurses were women, and all had previously been healthy except for one who had diabetes. Two had asymptomatic cases of MERS-CoV infection, one had only a runny nose, and four reported mild symptoms. They did not require treatment, recovered fully within a week, and remained healthy on follow-up. On daily follow-up PCR testing, six of seven tested positive for MERS-CoV on day 2 and negative on day 3; one remained positive until day 8. There was no history of exposure to animals or to persons with MERS-CoV infection in the community, and no subsequent cases of MERS-CoV were associated with these seven health care workers.
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Correspondence Copyright © 2013 Massachusetts Medical Society. corrections Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus (August 1, 2013; 369:407-16) . In the Results section, the second sentence under Demographic and Clinical Features (page 412) should have read, "The most common signs and symptoms were fever (in 87% of the patients) and cough (in 87%) . . . ," rather than ". . . and cough (in 89%) . . . ." In Question 1 of the Continuing Medical Education examination associated with this article (page 495), choice A should have read, "Shortness of breath," rather than "Cough." The article and the examination are correct at NEJM.org.
Genetically Informed Therapy in Leukemia (May 9, 2013; 368: 1838-9) . In the first two sentences of the second paragraph (page 1838), CSF3R is erroneously described as a tyrosine kinase. In the first sentence, the expression "another tyrosine kinase mutation" should be "a mutation," and in the second sentence, the expression "encoding the tyrosine kinase CSF3R" should be "encoding CSF3R." The article is correct at NEJM.org.
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The following forums will be held: "Stem Cells in Translation" (Florence, Italy, Sept. 15-18) and "Stem Cells in Science and Medicine" (Suzhou, China, 
CRRT 2014
The conference, entitled "Acute Kidney Injury: Controversies, Challenges, and Solutions -Advances in Critical Care," will be held in San Diego, CA, March 4-7. It is jointly sponsored by Continuous Renal Replacement Therapies and the University of California San Diego School of Medicine.
Contact CRRT Administration, RES Seminars, 4425 Cass St., Suite A, San Diego, CA 92109; or e-mail res@crrtonline.com; or see http://www.crrtonline.com/conference.
hEAl 2014 (hEARinG ACRoSS ThE liFESpAn)
The conference, entitled "Early Intervention: the Key to Better Hearing Care," will be held in Cernobbio (Lake Como), Italy, June 5-7.
Contact Meet and Work Srl, Piazza del Sole e della Pace 5, 35031 Abano Terme (Padova), Italy; or e-mail nhs@polimi.it; or see http://www.heal2014.org.
10Th mAlAySiA GEnETiCS ConGRESS
The congress will be held in Kuala Lumpur, Malaysia, Dec. 3-5. It is presented by the Genetics Society of Malaysia.
Contact Ms. Marcus Chew, 10th Malaysia Genetic Congress, c/o Console Communication, Suite 12.9, Level 12, Wisma UOA II, 21, Jalan Pinang, 50450 Kuala Lumpur, Malaysia; or call (603) 2162 0566; or fax (603) 2161 6560; or e-mail mgc2013@ console.com.my; or see http://www.persatuangenetikmalaysia .com.
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